Author

Robert Saddawi‐Konefka

Moores Cancer CenterORCID 0000-0002-9936-1695Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

Jorge Silvio GutkindiD· 2 shared Abdula MontheriD· 1 shared Andrew B. SharabiiD· 1 shared Catherina L. SalangaiD· 1 shared Chad Philips· 1 shared Cheyanne K. ShinniD· 1 shared Cynthia Y. TangiD· 1 shared Joseph A. CalifanoiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jorge Silvio GutkindORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD47 blockade enhances immunoradiotherapy response in head and neck squamous cell carcinoma

Abdula Monther, Riyam Al Msari, Robert Saddawi‐Konefka, Santiago Fassardi, Cynthia Y. Tang, Chad Philips, Prakriti Sen, Pardis Mohammadzadeh, Kelsey Decker, Sayuri Miyauchi, Roy S, Riley N. Jones, Jorge Silvio Gutkind, Andrew B. Sharabi, Joseph A. Califano

This study shows CD47 blockade combined with anti-PD1 and radiotherapy improves tumor response in HNSCC by enhancing antigen presentation and immune cell infiltration.

bioRxiv · Jun 29, 2025 · PreprintCancer Biology

Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma

Cheyanne K. Shinn, Robert Saddawi‐Konefka, Catherina L. Salanga, Shiruyeh Schokrpur, Jorge Silvio Gutkind, Tracy M. Handel

This study shows that delivering CXCL10 into tumors enhances immune cell infiltration, activation, and anti-tumor responses, and improves the effectiveness of immunotherapy in head and neck squamous cell carcinoma.

bioRxiv · Apr 24, 2025 · PreprintCancer Biology